Get the Stockscreener App
4.39
7.23%
-0.31
Novabridge Biosciences Adr stock is traded at $4.39, with a volume of 562.24K.
It is down -7.23% in the last 24 hours and up +0.00% over the past month.
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
See More
Previous Close:
$4.70
Open:
$4.5
24h Volume:
562.24K
Relative Volume:
36.48
Market Cap:
$504.25M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.25
$4.85
1-Week Range:
$4.25
$5.14
52-Week Range:
$4.25
$5.14
Novabridge Biosciences Adr Stock (NBP) Company Profile
Name
Novabridge Biosciences Adr
Sector
Industry
Phone
-
Address
-
Compare NBP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NBP
Novabridge Biosciences Adr
|
4.385 | 541.75M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.37 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.93 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.31 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.08 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.73 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Novabridge Biosciences Adr Stock (NBP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-25 | Initiated | Leerink Partners | Outperform |
| Sep-09-25 | Initiated | BTIG Research | Buy |
| Dec-09-21 | Initiated | Siebert Williams Shank | Buy |
| Jun-02-21 | Initiated | Daiwa Securities | Buy |
| Mar-15-21 | Initiated | Needham | Buy |
| Mar-03-21 | Reiterated | H.C. Wainwright | Buy |
| Feb-25-21 | Initiated | Piper Sandler | Overweight |
| Dec-07-20 | Initiated | H.C. Wainwright | Buy |
| Jul-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-12-20 | Initiated | China Renaissance | Buy |
| Feb-11-20 | Initiated | Jefferies | Buy |
View All
Novabridge Biosciences Adr Stock (NBP) Financials Data
There is no financial data for Novabridge Biosciences Adr (NBP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.09%
0.46%
Cap:
|
Volume (24h):